Mumbai, India, May 29, 2018 Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the fourth quarter and year ended March 31, 2018. For the fourth quarter ended March 31, 2018, Glenmark’s consolidated revenue  →